Joint Filing AgreementJoint Filing Agreement • January 27th, 2014 • Aspire Capital Fund, LLC • Pharmaceutical preparations
Contract Type FiledJanuary 27th, 2014 Company IndustryThe undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13G, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • July 2nd, 2020 • Aspire Capital Fund, LLC • Pharmaceutical preparations
Contract Type FiledJuly 2nd, 2020 Company IndustryThis Joint Filing Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original instrument, but all of such counterparts together shall constitute one agreement.
JOINT FILING AGREEMENTJoint Filing Agreement • July 2nd, 2020 • Aspire Capital Fund, LLC • Pharmaceutical preparations
Contract Type FiledJuly 2nd, 2020 Company IndustryThis Joint Filing Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original instrument, but all of such counterparts together shall constitute one agreement.
Joint Filing AgreementJoint Filing Agreement • February 17th, 2015 • Aspire Capital Fund, LLC • Pharmaceutical preparations
Contract Type FiledFebruary 17th, 2015 Company IndustryThe undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13G, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • December 23rd, 2020 • Aspire Capital Fund, LLC • Pharmaceutical preparations
Contract Type FiledDecember 23rd, 2020 Company IndustryThis Joint Filing Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original instrument, but all of such counterparts together shall constitute one agreement.
Joint Filing AgreementJoint Filing Agreement • February 17th, 2015 • Aspire Capital Fund, LLC • Pharmaceutical preparations
Contract Type FiledFebruary 17th, 2015 Company IndustryThe undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13G, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
Joint Filing AgreementJoint Filing Agreement • November 20th, 2014 • Aspire Capital Fund, LLC • Pharmaceutical preparations
Contract Type FiledNovember 20th, 2014 Company IndustryThe undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13G, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • February 17th, 2021 • Aspire Capital Fund, LLC • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 17th, 2021 Company IndustryThis Joint Filing Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original instrument, but all of such counterparts together shall constitute one agreement.